• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Diagnostic Markets for Women’s Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing)

$150.00 – $300.00

Clear
SKU: KLI2832946 Categories: Diagnostics Market Research, Medical Imaging & In Vivo Testing Pages: 150
  • Description
  • Table of Contents
  • Latest reports

Description

Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. However, during the past two decades, there have been major changes in government and private support of women’s health research — in policies, regulations, and the organization of research efforts. In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the past 20 years in lessening the burden of disease and reducing deaths from some conditions for women, while other conditions have seen only moderate change or even little or no change.

This Kalorama Information report, Diagnostic Markets for Women’s Health provides insight into this key area of testing. The following tests are among those covered in this report.

  • Pregnancy and Ovulation Tests
  • Bone Density Testing
  • Prenatal Screening
  • Ultrasound
  • Mammography
  • Pap Smears
  • Colposcopy
  • HPV Testing
  • Ovarian Cancer Tests
  • UTI Testing
  • Neonatal Jaundice Testing
  • Auto Immune Disease Testing
  • Cystic Fibrosis Testing

Market size and forecast are provided for these testing markets.

Women make more than 75% of the health care decisions in American households and spend almost two of every three health care dollars. Women also make more than 65% of physician visits, 62% of prescription drug purchases, and 76% of the nursing home population. The life expectancy of women is longer than for men and is climbing steadily due to advancements in medicine. Yet, female health is an area that has much room for improvement both in the development of products and the treatment of diseases.

This report analyzes the current and potential world markets for key diagnostic tests targeted at women’s health. This report generally forecasts future market growth for these tests to 2015. Market segments covered include the world and North American markets.
This report also reviews the nature and direction of research and trends, and gives insight into some issues facing the industry.

The report profiles several key companies, including large companies that have made names for themselves in the field, as well as smaller firms with market niches. These companies are involved in developing and marketing over the counter (OTC), point of care (POC) in vitro diagnostic (IVD) tests and screening systems. Some of the companies profiled include

  • GE Healthcare
  • Hologic
  • Perkin Elmer
  • Philips Healthcare
  • Siemens Healthcare
  • Somagen Diagnostics.

Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. The market data are generated into multiple year forecasts for different product segments covered in the report. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives and researchers.

All Kalorama reports advertise the single user price. Use is limited to one user. We also feature department and global pricing for reports that we be utilized by more than one user at your company. Please consult ask your sales representative or select the correct license on our website.

For Kalorama’s take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information’s Key Point Blog at http://kaloramakeypoint.blogspot.com/

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

1.1 Women’s Health in Focus

1.2 Diagnostics Moving Forward

1.2.1 Advancing Female Health

1.2.2 Studying the Most Relevant Groups

1.2.3 Translating Research into Practice

1.3 Key Issues Involving Women’s Health

1.4 Market Picture

1.4.1 Overall Trends

1.4.2 Key Diagnostic Forecasts

1.4.3 Methodology

CHAPTER TWO: INTRODUCTION

2.1 Perspective on Women’s Health

2.2 Key Differences between the Sexes

2.2.1 Autoimmune Disease

2.2.2 Cancer

2.2.3 Musculoskeletal Health

2.2.4 Birth Defects

2.2.5 Urinary Tract Infections

2.3 Key Leading Causes of Death in Females

2.4 Demographics

2.4.1 What Claims Women’s Lives

2.5 Key Trends and Issues in Women’s Diagnostics

2.5.1 Understanding the Molecular Basis of Disease

2.5.2 Managing Cancer Disease and Costs

2.5.3 Ultrasound and Mammography Use Grows

CHAPTER THREE: PREGNANCY AND OVULATION

3.1 Perspective on Testing

3.1.1 Digital Testing

3.2 OTC Test Market Forecast

3.3 Church & Dwight Co. Inc.

3.4 Inverness Medical Innovations

3.5 Siemens Healthcare Diagnostics

CHAPTER FOUR: BONE DENSITY TESTING

4.1 Alarming Rise of Osteoporosis

4.1.1 Bone Mineral Density

4.1.2 Refining Diagnosis

4.2 Bone Densitometer Market Forecast

4.3 GE Healthcare

4.4 Hologic

4.5 Osteometer MediTech

CHAPTER FIVE: PRENATAL SCREENING

5.1 Perspective

5.1.1 Advances

5.2 Value of Informed Choice

5.3 The Impact of Prenatal Genetic Testing

5.4 DNA Assay Market Forecast

5.5 PerkinElmer

5.6 Quest Diagnostics

5.7 Sequenom

CHAPTER SIX: ULTRASOUND

6.1 History and Perspective

6.1.1 Advances in Technology

6.2 Obstetrics and Gynecology

6.3 Breast Imaging

6.4 Market Forecasts

6.4.1 Ob/Gyn Market

6.4.2 Breast Imaging

6.5 Analogic

6.6 Philips Healthcare

6.7 Siemens Healthcare

CHAPTER SEVEN: MAMMOGRAPHY

7.1 Perspective

7.1.1 Routine Screening

7.2 Transitioning to Digital

7.3 Computer-Aided Detection

7.4 Market Forecasts

7.4.1 Mammography Systems

7.4.2 CAD

7.5 Carestream Health

7.6 FujiFilm Medical Systems USA

7.7 GE Healthcare

7.8 Hologic

CHAPTER EIGHT: PAP SMEARS

8.1 Testing for Cervical Cancer

8.1.1 Types of Screening

8.2 Cervical Cancer Shot

8.3 A Market Need

8.3.1 IVD Market Forecasts

8.4 Becton Dickinson

8.5 Hologic

8.6 Innogenetics NV

CHAPTER NINE: COLPOSCOPY

9.1 Biopsy Procedure

9.1.1 Pap Smear Concerns

9.1.2 Routine Use

9.2 Markets for Colposcopy Systems

9.2.1 Primary and Secondary Screening

9.3 CooperSurgical 95 Corporate Dr. Trumbull, CT 06611

9.4 Guided Therapeutics

9.5 NeoDiagnostix

CHAPTER TEN: HPV TESTING

10.1 HPV Defined

10.1.1 High Risk Types

10.1.2 Relationship to Cervical Cancer

10.2 Vaccine Issues

10.3 Strong Market Expected

10.3.1 IVD Market Forecasts

10.4 Abbott Diagnostics

10.5 Hologic

10.6 Qiagen Benelux BV

CHAPTER ELEVEN: OVARIAN CANCER

11.1 Types of Ovarian Cancer

11.2 Different Diagnostic Techniques

11.3 Tumor Markers and Antigens

11.4 CA-125 Market Forecast

11.5 Abbott Diagnostics

11.6 Fujirebio Diagnostics

CHAPTER TWELVE: URINARY TRACT INFECTIONS

12.1 Leading Cause of Morbidity and Death

12.1.1 Impact of Hospital Acquired Infections

12.1.2 Impact on Women

12.2 E. coli the Key Culprit

12.3 Market Forecasts Molecular Testing

12.4 Amerifit

12.5 Liofilchem

12.6 Rheonix

12.7 Somagen Diagnostics

CHAPTER THIRTEEN: NEONATAL JAUNDICE

13.1 Issues Involving Bilirubin

13.2 Two Factors in Neonates

13.3 Risk Factors

13.4 Autism Link

13.5 Market Forecasts Bilirubin Testing

13.6 Instrumentation Laboratory

13.7 Nova Biomedical

13.8 Siemens Healthcare Diagnostics

13.9 Wako Diagnostics

CHAPTER FOURTEEN: AUTOIMMUNE DISEASE

14.1 Genetic Factors

14.2 Low-Level Autoimmunity

14.3 Impact on Females

14.4 Types of Autoimmune Disease

14.5 IVD Market Forecasts

14.6 Bio-Rad Laboratories

14.7 Kronus

14.8 Phadia

14.9 XDx

CHAPTER FIFTEEN: CYSTIC FIBROSIS

15.1 Affecting the Entire Body

15.2 Reduced Life Expectancy

15.3 Genetics

15.4 Chronic Infections

15.5 Market Forecast Genetic Testing

15.6 AutoGenomics

15.7 GenMark Diagnostics

15.8 Gen-Probe

15.9 Luminex

15.10 Sequenom

 

    30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025 (June 2025 Update)
    June 25, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    June 24, 2025
    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025

Related products

  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00
  • Placeholder image

    U.S. Market for Molecular Diagnostics, 2nd Edition

    $3,500.00 – $7,000.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    Molecular Imaging Agents and Systems – A Market Briefing

    $995.00 – $1,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Asian Vaccine Markets: India, China, Japan, Korea, Indonesia and Rest of As...Surgical Procedure Volumes in Europe
Scroll to top